These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1180 related items for PubMed ID: 16755210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS, Bredikis A, Habib G, Carabello BA, Ramasubbu K, Bozkurt B.
    Am J Cardiol; 2008 Nov 15; 102(10):1356-60. PubMed ID: 18993155
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. What is the optimal medical management of ischemic heart failure?
    Cleland JG, Alamgir F, Nikitin NP, Clark AL, Norell M.
    Prog Cardiovasc Dis; 2001 Nov 15; 43(5):433-55. PubMed ID: 11251129
    [Abstract] [Full Text] [Related]

  • 6. Treatment of heart failure with preserved systolic function.
    de Groote P, Herpin D, Diévart F, Hanon O, Trochu JN, Artigou JY, Galinier M, Habib G, Juillière Y, Neuder Y, Roudaut R, Komajda M.
    Arch Cardiovasc Dis; 2008 May 15; 101(5):361-72. PubMed ID: 18656095
    [Abstract] [Full Text] [Related]

  • 7. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G, Sabbadini G, Zecchin M, Di Lenarda A.
    G Ital Cardiol (Rome); 2007 Sep 15; 8(9):559-67. PubMed ID: 17972425
    [Abstract] [Full Text] [Related]

  • 8. Type 2 diabetes mellitus and heart failure.
    Choy CK, Rodgers JE, Nappi JM, Haines ST.
    Pharmacotherapy; 2008 Feb 15; 28(2):170-92. PubMed ID: 18225964
    [Abstract] [Full Text] [Related]

  • 9. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005 Feb 15; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 15; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T, Takeshita A.
    Nihon Rinsho; 2003 May 15; 61(5):801-6. PubMed ID: 12755006
    [Abstract] [Full Text] [Related]

  • 17. Advances in the treatment of heart failure with a preserved ejection fraction.
    Das A, Abraham S, Deswal A.
    Curr Opin Cardiol; 2008 May 15; 23(3):233-40. PubMed ID: 18382212
    [Abstract] [Full Text] [Related]

  • 18. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D, Marshall R, Soisson K.
    Lippincotts Prim Care Pract; 1999 May 15; 3(3):316-32. PubMed ID: 10711133
    [Abstract] [Full Text] [Related]

  • 19. Heart failure.
    McKelvie R.
    Clin Evid; 2004 Dec 15; (12):115-43. PubMed ID: 15865633
    [No Abstract] [Full Text] [Related]

  • 20. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G.
    Ital Heart J; 2004 Dec 15; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.